-
平臺(tái)編號(hào)：bio-68708
-
國(guó)際編號(hào)：CRL-11116?
-
細(xì)胞信息： 36.5
-
規(guī)格：frozen
-
用途：ATCC原裝細(xì)胞
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
36.5
細(xì)胞形態(tài)：上皮樣
生長(zhǎng)狀態(tài)：貼壁生長(zhǎng)
ATCC Number：CRL-11116?
品系：129/Sv+c/+p
數(shù)量：大量
細(xì)胞類型：其他細(xì)胞類型
器官來(lái)源：胚胎
是否是腫瘤細(xì)胞：0
物種來(lái)源：小鼠
年限：embryo, blastocyst
運(yùn)輸方式：凍存運(yùn)輸
規(guī)格： 100人份 Designations: 36.5
Depositors: ?Ontario Cancer Institute
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:adherent
Organism: Mus musculus
Morphology:epithelial
Source: Organ: embryo
Strain: 129/Sv+c/+p
Cell Type: pluripotent embryonic stem cell;
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Age: embryo, blastocyst
Comments:This line was derived by inserting a construct containing a disrupted murine Lyt-2 (CD8) gene.
The Lyt-2 genes was disrupted by insertion of a plasmid containing a neomycin resistance gene into the first exon of the Lyt-2 gene.
After selection for neomycin resistance and presence of Lyt-2 sequences upstream of the insertion, the 36.5 cell line was established.
This line has been used to produce mice deficient in expression of CD8.
The cells can be maintained in the undifferentiated state by frequent subculture on feeder layers of irradiated (12000 rads) or mitomycin C treated (0.01 mg/ml for 90 minutes) primary mouse embryonic fibroblasts or STO cells.
(see ATCC CRL-1503 or ATCC 56-X, irradiated STO cells).
Propagation: ATCC complete growth medium: Dulbecco's modified Eagle's medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate and 4.5 g/L glucose and supplemented with 0.1 mM 2-mercaptoethanol, 85%; fetal bovine serum, 15%
Temperature: 37.0°C
Subculturing: Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:6 is recommended
Medium Renewal: Every 2 to 3 days
Remove medium and rinse the monolayer with fresh 0.25% trypsin, 0.03% EDTA solution. Remove the trypsin and incubate at 37C until the cells detach (approximately 10 minutes). Add fresh medium, aspirate and dispense onto fresh feeder layer cultures.
Preservation: culture medium 95%; DMSO, 5%
Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
recommended serum:ATCC 30-2020
feeder layer cells:ATCC 56-X
References: 22100: Mak TW. Mutant mouse lacking CD8 surface marker. US Patent 5,530,178 dated Jun 25 1996
生長(zhǎng)狀態(tài)：貼壁生長(zhǎng)
ATCC Number：CRL-11116?
品系：129/Sv+c/+p
數(shù)量：大量
細(xì)胞類型：其他細(xì)胞類型
器官來(lái)源：胚胎
是否是腫瘤細(xì)胞：0
物種來(lái)源：小鼠
年限：embryo, blastocyst
運(yùn)輸方式：凍存運(yùn)輸
規(guī)格： 100人份 Designations: 36.5
Depositors: ?Ontario Cancer Institute
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:adherent
Organism: Mus musculus
Morphology:epithelial
Source: Organ: embryo
Strain: 129/Sv+c/+p
Cell Type: pluripotent embryonic stem cell;
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Age: embryo, blastocyst
Comments:This line was derived by inserting a construct containing a disrupted murine Lyt-2 (CD8) gene.
The Lyt-2 genes was disrupted by insertion of a plasmid containing a neomycin resistance gene into the first exon of the Lyt-2 gene.
After selection for neomycin resistance and presence of Lyt-2 sequences upstream of the insertion, the 36.5 cell line was established.
This line has been used to produce mice deficient in expression of CD8.
The cells can be maintained in the undifferentiated state by frequent subculture on feeder layers of irradiated (12000 rads) or mitomycin C treated (0.01 mg/ml for 90 minutes) primary mouse embryonic fibroblasts or STO cells.
(see ATCC CRL-1503 or ATCC 56-X, irradiated STO cells).
Propagation: ATCC complete growth medium: Dulbecco's modified Eagle's medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate and 4.5 g/L glucose and supplemented with 0.1 mM 2-mercaptoethanol, 85%; fetal bovine serum, 15%
Temperature: 37.0°C
Subculturing: Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:6 is recommended
Medium Renewal: Every 2 to 3 days
Remove medium and rinse the monolayer with fresh 0.25% trypsin, 0.03% EDTA solution. Remove the trypsin and incubate at 37C until the cells detach (approximately 10 minutes). Add fresh medium, aspirate and dispense onto fresh feeder layer cultures.
Preservation: culture medium 95%; DMSO, 5%
Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
recommended serum:ATCC 30-2020
feeder layer cells:ATCC 56-X
References: 22100: Mak TW. Mutant mouse lacking CD8 surface marker. US Patent 5,530,178 dated Jun 25 1996
